146 related articles for article (PubMed ID: 9987506)
1. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
Inuyama Y; Kataura A; Togawa K; Saijo S; Satake B; Takeoda S; Konno A; Ebihara S; Sasaki Y; Kida A; Kanzaki J; Ichikawa G; Kono N; Moriyama H; Kamata S; Miyake H; Sakai M; Horiuchi M; Kubota A; Tsukuda M; Matsuura H; Baba S; Saito H; Matsunaga T; Taguchi T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):107-16. PubMed ID: 9987506
[TBL] [Abstract][Full Text] [Related]
2. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
[TBL] [Abstract][Full Text] [Related]
3. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
4. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Verweij J; Mattijssen V; Hanauske A; Piccart M; Wanders J; Franklin H; Le Bail N; Clavel M; Kaye SB
Ann Oncol; 1994 Jul; 5(6):533-7. PubMed ID: 7918125
[TBL] [Abstract][Full Text] [Related]
6. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
Taguchi T; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1915-24. PubMed ID: 9797814
[TBL] [Abstract][Full Text] [Related]
7. [Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].
Noda K; Terajima Y; Ogita Y; Kono I; Hirabayashi K; Yakushiji M; Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2471-7. PubMed ID: 7944493
[TBL] [Abstract][Full Text] [Related]
8. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
[TBL] [Abstract][Full Text] [Related]
10. [An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer].
Taguchi T; Hirata K; Kunii Y; Tabei T; Suwa T; Kitajima M; Adachi I; Tominaga T; Shimada H; Sano M
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2453-60. PubMed ID: 7944491
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck.
Specht L; Larsen SK; Hansen HS
Ann Oncol; 2000 Jul; 11(7):845-9. PubMed ID: 10997812
[TBL] [Abstract][Full Text] [Related]
12. [Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer].
Yokoyama A; Kurita Y; Watanabe K; Negoro S; Ogura T; Nakano M; Minoda S; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2609-16. PubMed ID: 7979421
[TBL] [Abstract][Full Text] [Related]
13. Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel.
Schöffski P; Weihkopf T; Ganser A
Anticancer Res; 1998; 18(6B):4751-6. PubMed ID: 9891552
[TBL] [Abstract][Full Text] [Related]
14. [Late phase II trial of RP56976 (Docetaxel) in patients with non-small-cell lung cancer].
Onoshi T; Watanabe K; Furuse K; Kurita Y; Sugiura T; Sato K; Fujii M; Oizumi K; Abe S; Inoue Y
Gan To Kagaku Ryoho; 1995 Jan; 22(1):59-65. PubMed ID: 7826079
[TBL] [Abstract][Full Text] [Related]
15. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
16. [Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer].
Kudo S; Hino M; Fujita A; Igarashi T; Arita K; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2617-23. PubMed ID: 7979422
[TBL] [Abstract][Full Text] [Related]
17. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Formanek M; Selzer E; Burian M; Kornfehl J; Fiebiger W; Cartellieri M; Marks B; Kornek GV
Oncology; 2002; 63(2):145-50. PubMed ID: 12239449
[TBL] [Abstract][Full Text] [Related]
18. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
J Clin Oncol; 2001 Feb; 19(4):1096-104. PubMed ID: 11181674
[TBL] [Abstract][Full Text] [Related]
20. Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer.
Guardiola E; Peyrade F; Chaigneau L; Cupissol D; Tchiknavorian X; Bompas E; Madroszyk A; Ronchin P; Schneider M; Bleuze JP; Blay JY; Pivot X
Eur J Cancer; 2004 Sep; 40(14):2071-6. PubMed ID: 15341981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
